IP Library › Patent Application 19020135
Patent Application
App. No. 19/020,135

EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND OF LSD ANALOGS TO ASSIST PSYCHOTHERAPY FOR GENERALIZED ANXIETY DISORDER OR OTHER ANXIETY NOT RELATED TO LIFE-THREATENING ILLNESS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/020,135
Abstract

A method of treating anxiety disorders specifically not associated with causes such as a life-threatening serious somatic illness, by administering a psychedelic to an individual, and treating anxiety and specifically causing reductions in the rating scale score measures of anxiety (STAI global or state or trait anxiety) and/or measures of depression (HDRS or BDI scores) and/or measures of general psychological distress (SCL-90 ratings) in the patient for several weeks beyond administration of the psychedelic. A method of treating anxiety, by administering a psychedelic (preferably LSD) to an individual having anxiety not associated with causes such as a life-threatening serious somatic illness, and inducing positive acute drug effects and positive long-term therapeutic effects in the individual.

Claims (17)

1 .- 17 . (canceled)

18 . A method of treating generalized anxiety disorder in an individual comprising:

administering 25-400 μg of LSD, or a salt thereof, wherein the administration of 25-400 μg of LSD, or a salt thereof, results in a reduced STAI global score.

19 . The method of claim 18 , wherein a second dose of LSD, or a salt thereof, is administered four to five weeks after said administering step.

20 . The method of claim 18 , when the subject also has depression or low mood associated or co-present with the anxiety.

21 . The method of claim 18 , wherein the administration of LSD, or a salt thereof, results in reduced psychological distress.

22 . The method of claim 18 , wherein the administration of LSD, or a salt thereof, results in an increased quality of life in the individual.

23 . The method of claim 18 , further including the step of providing psychotherapy to the individual on separate days before and after administration of LSD, or a salt thereof.

24 . The method of claim 23 , wherein the administration of LSD, or a salt thereof, enhances the therapeutic effect of the psychotherapy.

25 . The method of claim 18 , wherein the LSD, or a salt thereof, is administered in the presence of a therapist for 12 hours in a quiet room.

26 . The method of claim 25 , wherein the individual is lying in a bed or sitting in a chair and listening to music.

27 . The method of claim 19 , wherein the second dose of LSD, or a salt thereof, is administered in the presence of a therapist for 12 hours in a quiet room.

28 . The method of claim 27 , wherein the individual is lying in a bed or sitting in a chair and listening to music.

29 . The method of claim 18 , wherein the individual was tapered off an antidepressant at least two weeks before administration of LSD, or a salt thereof.

30 . The method of claim 18 , wherein the STAI global score is reduced by 10-points in about four weeks or greater after administration of LSD, or a salt thereof.

31 . The method of claim 18 , wherein the STAI global score is reduced by 10-points in about ten weeks or greater after administration of LSD, or a salt thereof.

32 . The method of claim 18 , wherein the STAI global score is reduced by 20-points in about ten weeks or greater after administration of LSD, or a salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2025
From: LIECHTI, MATTHIAS EMANUEL; HOLZE, FRIEDERIKE SOPHIE
To: UNIVERSITÄTSSPITAL BASEL
Reel/Frame 070320/0839 →